-
Elobixibat hydrate: IBAT Assay Workflows
2026-09-15
Elobixibat hydrate enables a mechanism-led approach to gut research by connecting ileal bile acid transport with colonic secretion, motility, and enteroendocrine signaling. This guide differentiates workflows for chronic constipation, colonoscopy preparation models, and metabolic studies while emphasizing formulation control and translational limits.
-
Spatial Proteomics of Therapeutic Neural Probes
2026-09-15
This study develops titania nanotube array-coated intracortical probes as multifunctional interfaces that combine antimicrobial activity with localized therapeutic release. Spatial proteomic analysis identifies how neuronal integrity, immune activation, cytokines, and probe-side geometry can guide strategies for reducing chronic neuroinflammation and preserving neural recordings.
-
Verapamil ((±)-Verapamil) in Hypoxic Inflammation
2026-09-14
Verapamil is more than a cardiovascular research compound: in hypoxic urothelial models, it can serve as a mechanistic perturbation tool for examining ROS/TXNIP/NLRP3-linked inflammation. This article interprets the evidence, defines practical validation parameters, and explains why its calcium-channel and P-glycoprotein pharmacology must be considered when translating findings.
-
Pepstatin A Workflows for Aspartic Protease Studies
2026-09-14
Pepstatin A enables targeted interrogation of aspartic proteases across enzyme assays, viral protein processing research, and osteoclast models. This practical guide connects inhibitor handling with macrophage infection questions raised by a recent SARS-CoV-2 study while separating established evidence from testable extensions.
-
BIBR 1532: Telomerase Inhibition by Design
2026-09-13
BIBR 1532 is a selective telomerase inhibitor for dissecting hTERT-dependent cancer biology. This article explains how to distinguish direct telomerase suppression, telomere attrition, DNA damage, and apoptosis using an integrated assay strategy informed by recent CF10–EdU research.
-
MK-571 (L-660,711): Applied Research Workflows
2026-09-12
MK-571 (L-660,711) supports two distinct experimental use-cases: cysteinyl leukotriene receptor 1 blockade in airway inflammation models and MRP1/ABCC1 interrogation in macrophage drug-response studies. This guide connects mechanism, assay design, formulation, controls, and troubleshooting for more interpretable inflammation and transporter experiments.
-
Sulforaphane, PM2.5, and COPD Redox Signaling
2026-09-12
The 2026 Phytotherapy Research study links sulforaphane protection against PM2.5-associated COPD injury to coordinated activation of Nrf2 and suppression of EGFR/PI3K/AKT signaling. Its integrated rat, cell, network pharmacology, docking, and EGFR-silencing design provides a mechanistic framework for studying particulate-matter-induced oxidative stress, while also highlighting the limits of translating a concurrent-exposure model to established human COPD.
-
Naftifine HCl in Antifungal Research Workflows
2026-09-11
Build more interpretable antifungal assays with Naftifine HCl, from solvent selection and dose-response design to sterol-pathway validation. The workflow also shows how to use the WNT5a/GSK3/β-catenin literature as a disciplined comparator without overextending evidence into unrelated muscle biology.
-
Tropifexor (LJN452) FXR Research Workflows
2026-09-11
Tropifexor (LJN452) enables precise FXR activation studies across intestinal barrier, metabolic, and liver disease models. This guide translates its subnanomolar potency into practical assay design, workflow controls, and troubleshooting strategies while distinguishing established evidence from recommended experimental extensions.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-10
ARCA Cy5 EGFP mRNA (5-moUTP) separates cellular uptake from productive translation through paired Cy5 and EGFP readouts. This practical workflow helps optimize mRNA transfection in mammalian cells, compare delivery systems, and troubleshoot localization, stability, and innate-response confounders.
-
Sodium Ascorbate: Cancer Assay Workflow
2026-09-10
Build reproducible redox and tumor-cell assays with Sodium Ascorbate, from fresh DMSO stock preparation through ROS, viability, and motility measurements. The workflow also shows how to use this mineral salt of ascorbic acid alongside—not as a substitute for—biomarker studies in immuno-oncology.
-
WEHI-539: A Translational Map of BCL-XL Dependence
2026-09-09
A thought-leadership guide to using WEHI-539 as a mechanistically precise BCL-XL inhibitor for mapping apoptotic dependence, interpreting cancer stem cell phenotypes, and strengthening translational study design.
-
Estradiol and the ER–Autophagy Axis in Aging
2026-09-09
A recent study integrates NHANES data, a perimenopausal mouse model, network pharmacology, and inhibitor-based validation to examine how declining estradiol affects the heart, aorta, and kidneys. Its findings connect estrogen receptor signaling with mTOR-related autophagy and tissue protection, while also showing why the results remain a mechanistic basis for further translational research rather than a clinical treatment recommendation.
-
Dovitinib in Hypoxia-Aware Cancer Research
2026-09-08
Dovitinib (TKI-258) enables mechanism-focused studies of RTK signaling, apoptosis, and tumor adaptation under hypoxic stress. This workflow connects quantitative pathway inhibition with assay designs relevant to multiple myeloma research and hepatocellular carcinoma treatment research.
-
Methoxy-X04 for Mechanism-Resolved Aβ Imaging
2026-09-08
Methoxy-X04 is a fluorescent amyloid beta probe for distinguishing aggregate-associated pathology from broader treatment effects in Alzheimer’s disease research. This guide develops a mechanism-focused imaging strategy for connecting rTMS, microglial clearance, plaque burden, and cerebrovascular amyloid visualization.